|
Home Patient Education Organization Consultations Diabetes Hypertension Lipid disorder Thyroid Arthritis Fever Weight Reduction Asthma over view Jaundice Hepatitis A Sleep disorders Cardiac markers CT MRI Xray Discounts Lab tests Free camps For Patients For Doctors Pharma companies For students For schools Life Insurance Alerts Visitor page Donate About us Disclaimer Feed back |
Up | Introduction | Symptoms | Complications | Transmission | Prevention | Vaccination | Vaccine Quality | Vaccination schedule | Communicable disease
Hepatitis a vaccination-facts

 | Who recommends for all above age of 1 year in India. |
 | Seroconversion rate (effective antibody response) > 97 % after 1st dose. |
 | Safety of vaccine is excellent, having no major side effects. |
 | Protects all including high risk groups. |
 | Coupled with sanitation, can prevent epidemics in our country. |
 | Cost effective. (treatment cost of disease and loss of working hours leading to financial losses are manifold times than the cost of vaccination.) |
Vaccine and vaccination schedule
 | Vaccine is an inactivated hepatitis A virus.(HM175 Strain) |
 | Virus used for vaccine production, propagated on human diploid cells. |
Dose
 | Adults: 1ml (1440u) |
 | Age 1-18 years: 0.5 ml(720u) |
 | Dosage schedule: 2 doses ,6-12 months apart. |
 | Site of administration: deltoid (arm) in adults; thigh in children. |
 | Seroconversion rate of vaccine ( effective antibodies production.) > 97%. |
 | No major side effects. |
 | Protection is life long. |
 | Post exposure protection: possible with in 48 hours. ( vaccination of a person with in 48 hours of coming in contact with a known case of hepatitis A can prevent infection). | |